Warning letter
Joe Wise Pharmacy, Inc., dba Wise Pharmacy: warning letter of Apr 15, 2021
FDA warning letter 613927 · Division of Pharmaceutical Quality Operations IV
Key facts
| Reference number | 613927 |
|---|---|
| Company | Joe Wise Pharmacy, Inc., dba Wise Pharmacy |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Apr 15, 2021 |
| Posted date | Apr 27, 2021 |
| Issuing office | Division of Pharmaceutical Quality Operations IV |
| Product type | Drugs |
| Inspection city | Littleton |
| Inspection ZIP | 80123-3095 |
| Inspection start date | Jun 12, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: